Roadmap to prevention The USC Epstein Family Alzheimer's Therapeutic Research Institute accelerates treatments from lab to clinic.
San Diego, CA
Joined November 2017
- Tweets604
- Following117
- Followers560
- Likes362
USC Epstein Family ATRI retweeted
USC hosted a celebration for the renaming of the Epstein Family Alzheimer's Therapeutic Research Institute (@ATRI_USC).
The Epstein family's generosity is accelerating the path to Alzheimer’s prevention, solidifying @USC's role as the leader in #AlzheimersResearch.
ALT Two individuals stand smiling in front of the USC Epstein Family Alzheimer's Therapeutic Research Institute. Both are making peace signs with their hands.
ALT A group of individuals is standing in front of a sign for the USC Epstein Family Alzheimer's Therapeutic Research Institute. They are dressed in formal attire and smiling at the camera.
ALT A person speaking on an outdoor stage in front of a large white backdrop, with an audience seated in chairs. The building behind has the sign "Keck School of Medicine of USC.
ALT Four individuals stand in front of the USC Epstein Family Alzheimer's Therapeutic Research Institute building. They are dressed in formal attire and appear to be posing for a photo.
Dr. Robert Rissman met with the Rancho Santa Fe Rotary group to share how his labs are behind the new blood tests for early Alzheimer's detection, along with his many other scientific discoveries leading to dementia prevention AND a cure.
Yesterday, USC Epstein Family ATRI hosted its Second Annual Research Day, highlighting the work of our ATRI Summer Student Research Program as well as ATRI student trainees. Additionally, students were able to network with members of the community in both academia and industry.
Alzheimer's is the leading cause of death for people with Down syndrome. New findings from ATRI show that two blood tests identified Alzheimer's-related changes in people with Down syndrome with nearly the same accuracy.
For the full NewsWeek article: na2.hubs.ly/H070mWk0
In the News: Ambitious studies have been examining the protective effects of diet, exercise and socializing - with surprising results.
To read In the News: na2.hubs.ly/H06Y1LK0
The next frontier is tau. Studies such as the Alzheimer’s Tau Platform (ATP) clinical trial are now focused on testing potential treatments that target tau tangles.
For more information on the ATP trial, visit na2.hubs.ly/H06sDd50
By the Numbers: Alzheimer's Clinical Trials Consortium (ACTC) sites
For more information on ACTC studies and site information, visit na2.hubs.ly/H06krlL0.
The USC Epstein Family ATRI welcomed our class of 2026 Student Summer Research Program. For the next 8 weeks, these 11 students will assist in operations across ATRI, gaining hands on experience and knowledge about working in the field of Alzheimer's and related dementias.
This Alzheimer's and Brain Awareness Month, we invite you to share how Alzheimer's has touched your life. Your experiences help raise awareness, reduce stigma, and strengthen our commitment to advancing research and care. Send us your stories via DM or email [email protected]
The Alzheimer’s Prevention Trials (APT) Webstudy is a no-cost, online platform enabling participants to regularly track their brain health by completing brief cognitive assessments every three to six months. For more information on the APT Webstudy, visit: na2.hubs.ly/H05FwKD0
In the News: Biogen to advance experimental Alzheimer's drug despite mid-stage trial miss
Biogen will proceed with clinical testing of an investigational therapy designed to inhibit tau production in the brain. Read Dr. Mindy Aisen's commentary: na2.hubs.ly/H05DckR0
In the News: Why boosting dopamine backfires in the Alzheimer's brain
Part 2 on the link between dopamine and Alzheimer's Disease explores why dopamine may not benefit the Alzheimer's brain.
Read part 1: na2.hubs.ly/H05rvQq0
Read part 2: na2.hubs.ly/H05rt490
Be the Brain Behind the Change
The gift of brain donation is vital to improving Alzheimer's Disease treatment and prevention.
Read more about brain donation here: na2.hubs.ly/H05kF7y0
Read more about other studies at ATRI: na2.hubs.ly/H05kDgF0
USC will Infuse A.I. Across University with $200 Million Donation
Read comments from Dr. Gustavo Jimenez-Maggiora, ATRI's Head of Biomedical Informatics, AI, and Natural Language Processing.
na2.hubs.ly/H05j7k70
In the News: The Link Between Dopamine and Alzheimer's Disease
Join us for a 2-parter look into the link between Dopamine and Alzheimer's Disease. Dr. Mindy Aisen explores whether dopamine depletion is a hidden driver of Alzheimer's Disease. Read Part 1: na2.hubs.ly/H05h-Dg0
ATRI is Studying Your Immune Health and its Link to Alzheimer's Disease
New to ATRI, Dr. Oliver Bracko recently attended and presented his lab's work on complicated interactions between the immune system and neurodegenerative disease at USC's CPBH Annual Symposium.
Did You Know - Virtually all people with Down syndrome develop brain changes associated with Alzheimer's Disease (AD) by age 40? Approximately 95% will go on to develop dementia due to AD - now the leading cause of death among adults with Down syndrome.
The Alzheimer's Association reports that 1 in 3 older adults dies with Alzheimer's or another dementia, killing more adults than breast cancer and prostate cancer combined. For more information on our ongoing trials, visit our website: na2.hubs.ly/H05339s0
